Epidemiology of HIV-associated cryptococcosis in France (1985–2001)
- 1 February 2004
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 18 (3), 555-562
- https://doi.org/10.1097/00002030-200402200-00024
Abstract
Objective: To analyse the epidemiological evolution of cryptococcosis in France after the introduction of highly active antiretroviral therapy (HAART). Design: Retrospective study of cryptococcosis cases recorded at the National Reference Center for Mycoses in France since 1985. Methods: Using the national surveillance data, we reviewed 1644 cases of HIV-associated cryptococcosis diagnosed in France (population, 59 million) between 1985 and 2001 and compared them to 335 cases recorded in HIV-negative patients. Results: The total number of cryptococcosis cases evolved in parallel to that recorded for HIV-infected patients. Changes occurring after HAART introduction were analysed. A negative binomial regression model established a 46% decrease of the incidence of cryptococcosis during the post-HAART era (1997-2001, n = 292) compared to the pre-HAART era (1985-1996, n = 1352). According to multivariate analysis, African origin, older age, heterosexual HIV contamination, no previous AIDS-defining illness, and no previous HIV infection diagnosis were variables independently associated with an increased risk of cryptococcosis during the post-HAART era. During the same period, the characteristics of the HIV-negative population did not change. Conclusions: Our analysis of the national surveillance identified demographic factors associated with an increased risk of cryptococcosis in the post-HAART era suggesting that failure to consult and considering oneself not at risk were determinant in the current epidemiology of HIV-related cryptococcosis in France. (C) 2004 Lippincott Williams Wilkins.Keywords
This publication has 32 references indexed in Scilit:
- The Changing Epidemiology of Cryptococcosis: An Update from Population‐Based Active Surveillance in 2 Large Metropolitan Areas, 1992–2000Clinical Infectious Diseases, 2003
- Primary Cutaneous Cryptococcosis: A Distinct Clinical EntityClinical Infectious Diseases, 2003
- Epidemiology and Host- and Variety-Dependent Characteristics of Infection Due to Cryptococcus neoformans in Australia and New ZealandClinical Infectious Diseases, 2000
- Practice Guidelines for the Management of Cryptococcal DiseaseClinical Infectious Diseases, 2000
- Itraconazole Prophylaxis for Fungal Infections in Patients with Advanced Human Immunodeficiency Virus Infection: Randomized, Placebo‐Controlled, Double‐Blind StudyClinical Infectious Diseases, 1999
- Cryptococcosis: Population‐Based Multistate Active Surveillance and Risk Factors in Human Immunodeficiency Virus–Infected PersonsThe Journal of Infectious Diseases, 1999
- Changing patterns of mortality across Europe in patients infected with HIV-1The Lancet, 1998
- Cryptococcal Meningitis in Durban, South Africa: A Comparison of Clinical Features, Laboratory Findings, and Outcome for Human Immunodeficiency Virus (HIV)-Positive and HIV-Negative PatientsClinical Infectious Diseases, 1997
- Increasing incidence of cryptococcosis in the United KingdomJournal of Infection, 1993
- Expanded European AIDS case definitionThe Lancet, 1993